Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Addex Therapeutics reports positive results on ADX-71441

June 10, 2016

FDA awards fast track designation to Indivior's RBP-6000 buprenorphine monthly depot

May 27, 2016

FDA approves Probuphine for opioid dependence

May 27, 2016

Cerecor awarded NIDA grant

April 12, 2016

XT-150 as a potential solution for opioid abuse crisis

April 4, 2016

Cleveland BioLabs updates progress of entolimod pre-EUA review

March 17, 2016

Narcan now available in U.S. for the treatment of opioid overdose

Feb. 26, 2016

FDA lifts clinical hold on Aeolus's AEOL-10150 in acute radiation syndrome

Feb. 23, 2016

FDA extends Probuphine NDA review date

Feb. 22, 2016

EMA grants orphan drug status for entolimod as a radiation countermeasure

Jan. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...